D-dimer: is a fibrin degradation product, a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link. D-dimer concentration may be determined by a blood test to help diagnose thrombosis.
Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exp...
Coagulation tests are useful in the diagnosis and management of bleeding or thrombotic disorders. The majority of hospital and reference laboratories perform routine coagulation testing such...
Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. This webinar presentation will discuss the pathogenesis, incidence, clinical...
The diagnosis of venous thromboembolism (VTE) is challenging during pregnancy. Pregnant women often present with symptoms compatible with VTE. The use of conventional diagnostic algorithms is...
Getting It Right: Preanalytical Impact on Coagulation Results Using a Case Study Approach According to published literature, up to 65% of errors occur in the preanalytical phase of laborator...
According to published literature, up to 65% of errors occur in the preanalytical phase of laboratory testing, and coagulation assays are particularly sensitive to preanalytical issues......
The Patient is Bleeding: Balancing Clinical and Laboratory Needs Coagulopathy in the bleeding surgical patient can get worse by the second! One of the real-world operational challenges......
Perhaps more than any other area of clinical medicine, anticoagulation management laboratory data are evaluated hourly by healthcare systems in the inpatient setting and daily in the outpatie...
ASH Anticoagulation Guidelines in Patients with COVID-19: A moving target The American Society of Hematology (ASH) published in February 2021 “Anticoagulation Guidelines in Patients wi...
G protein-coupled receptors (GPCRs) are among the most intensively studied drug targets, and account for about ~34% of all drugs approved by the FDA. Examples of drugs targeting GPCRs includ...
Date: September 16, 2020 Time: 7:00am (PDT), 10:00am (EDT) Of the 15 million patients admitted to US based hospitals with medical, non-surgical illnesses, 8 million possess inherent risk of...
The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory tes...
Rapid access to high quality comprehensive coagulation test results is critical to patient care. In an environment where clinical laboratories constantly experience price and labor pressure,...
This talk will cover different approaches to emergency hemostasis testing for patients that are actively bleeding due to trauma, surgery, obstetrical emergencies and other causes. The talk i...
The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of inter...
DATE: September 10, 2019TIME: 8:00am PTNext generation sequencing of the immune repertoire allows detailed, sequence-specific insight into the immune system’s adaptive response...
Standardization and harmonization have come a long way in the last 3 to 4 decades; however, standardization is imperfect. Laboratory professional need to recognize the limitations of some of...
D-dimer is used in the clinical evaluation of suspected venous thromboembolism (VTE). Newer measurement methods show high sensitivity for this test, and in combination with pretest probabilit...
The D-dimer can be a useful tool in the management of patients with suspected or established venous thromboembolism (VTE). One use is in the assessment of a patient who presents with symptoms...
The first small molecule inhibitor of the molecular chaperone Heat Shock Protein 90 (HSP90) was identified more than 20 years ago. Upon determination of the drug binding site and clarificatio...
PATHFAST is a small, benchtop cardiac marker analyzer with industry-leading precision designed for ED and stat labs. PATHFAST is the only point-of-care cardiac biomarker analyzer in the marke...
Heparin-Induced Thrombocytopenia (HIT): Practical Aspects of Clinical and Laboratory Diagnosis Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exp...
Coagulation tests are useful in the diagnosis and management of bleeding or thrombotic disorders. The majority of hospital and reference laboratories perform routine coagulation testing such...
Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. This webinar presentation will discuss the pathogenesis, incidence, clinical...
The diagnosis of venous thromboembolism (VTE) is challenging during pregnancy. Pregnant women often present with symptoms compatible with VTE. The use of conventional diagnostic algorithms is...
Getting It Right: Preanalytical Impact on Coagulation Results Using a Case Study Approach According to published literature, up to 65% of errors occur in the preanalytical phase of laborator...
According to published literature, up to 65% of errors occur in the preanalytical phase of laboratory testing, and coagulation assays are particularly sensitive to preanalytical issues......
The Patient is Bleeding: Balancing Clinical and Laboratory Needs Coagulopathy in the bleeding surgical patient can get worse by the second! One of the real-world operational challenges......
Perhaps more than any other area of clinical medicine, anticoagulation management laboratory data are evaluated hourly by healthcare systems in the inpatient setting and daily in the outpatie...
ASH Anticoagulation Guidelines in Patients with COVID-19: A moving target The American Society of Hematology (ASH) published in February 2021 “Anticoagulation Guidelines in Patients wi...
G protein-coupled receptors (GPCRs) are among the most intensively studied drug targets, and account for about ~34% of all drugs approved by the FDA. Examples of drugs targeting GPCRs includ...
Date: September 16, 2020 Time: 7:00am (PDT), 10:00am (EDT) Of the 15 million patients admitted to US based hospitals with medical, non-surgical illnesses, 8 million possess inherent risk of...
The International Council for Standardization in Haematology (ICSH) is a nonprofit organization dedicated to providing open-access guidance documents to enhance the quality of laboratory tes...
Rapid access to high quality comprehensive coagulation test results is critical to patient care. In an environment where clinical laboratories constantly experience price and labor pressure,...
This talk will cover different approaches to emergency hemostasis testing for patients that are actively bleeding due to trauma, surgery, obstetrical emergencies and other causes. The talk i...
The compendium of newly emerging and currently available hemophilia and anticoagulant treatments, while offering new choices for improved patient care, can create significant levels of inter...
DATE: September 10, 2019TIME: 8:00am PTNext generation sequencing of the immune repertoire allows detailed, sequence-specific insight into the immune system’s adaptive response...
Standardization and harmonization have come a long way in the last 3 to 4 decades; however, standardization is imperfect. Laboratory professional need to recognize the limitations of some of...
D-dimer is used in the clinical evaluation of suspected venous thromboembolism (VTE). Newer measurement methods show high sensitivity for this test, and in combination with pretest probabilit...
The D-dimer can be a useful tool in the management of patients with suspected or established venous thromboembolism (VTE). One use is in the assessment of a patient who presents with symptoms...
The first small molecule inhibitor of the molecular chaperone Heat Shock Protein 90 (HSP90) was identified more than 20 years ago. Upon determination of the drug binding site and clarificatio...
PATHFAST is a small, benchtop cardiac marker analyzer with industry-leading precision designed for ED and stat labs. PATHFAST is the only point-of-care cardiac biomarker analyzer in the marke...
Follow
